Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.39 |
| ▸ | RCOR1 | Q9UKL0 | 3/20 | 0.39 |
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.39 |
| ▸ | GBA1 | P04062 | 2/20 | 0.36 |
| ▸ | TLR7 | Q9NYK1 | 5/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | BCL6 | P41182 | 2/20 | 0.33 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.33 |
| ▸ | KMT5A | Q9NQR1 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TRIM58 | Q8NG06 | 1/20 | 0.33 |
| ▸ | QPCT | Q16769 | 1/20 | 0.32 |
| ▸ | NMT1 | P30419 | 1/20 | 0.32 |
| ▸ | FLT3 | P36888 | 1/20 | 0.32 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.32 |
| ▸ | MERTK | Q12866 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6645858 | 0.81 | BCL6 (0.44) | KDM1ARCOR1EHMT2GBA1BCL6 | |
| SCHEMBL4836313 | 0.77 | MAPT (0.43) | EHMT2BCL6EHMT1 | |
| SCHEMBL4836660 | 0.75 | BCL6 (0.53) | KDM1ARCOR1EHMT2BCL6EHMT1 | |
| SCHEMBL4838558 | 0.67 | BCL6 (0.49) | EHMT2BCL6EHMT1 | |
| SCHEMBL4829068 | 0.67 | BCL6 (0.46) | EHMT2GBA1BCL6EHMT1 | |
| SCHEMBL4832263 | 0.67 | SLC2A1 (0.37) | EHMT2TLR7BCL6EHMT1KMT5A | |
| SCHEMBL4836307 | 0.67 | EHMT2 (0.47) | EHMT2BCL6EHMT1 | |
| SCHEMBL4838011 | 0.66 | BCL6 (0.55) | EHMT2BCL6EHMT1 | |
| SCHEMBL14421530 | 0.66 | BCL6 (0.40) | KDM1ARCOR1EHMT2GBA1BCL6 | |
| SCHEMBL14454103 | 0.66 | BCL6 (0.46) | EHMT2BCL6EHMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040077648-A1 | Methods and compositions of novel triazine compounds | DR. REDDY'S LABORATORIES LTD. (IN) | 2004-04-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077648-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | KDM1A 3351/4885RCOR1 2992/4885EHMT2 2905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.